OPKO Health, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
OPKO Health, Inc. (OPK) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-26
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2015-12-31 was -$2.00M.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2015-09-30 was $0.00.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2015-06-30 was $0.00.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2015-03-31 was $2.30M.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $300.00K, a 200.00% increase from fiscal 2023.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $100.00K.
- OPKO Health, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $300.00K 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | $100.00K 10-K · filed 2025-03-03 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | ||||
| 2021-12-31 | -$200.00K 10-K · filed 2023-02-27 | ||||
| 2020-12-31 | $100.00K 10-K · filed 2022-03-01 | ||||
| 2019-12-31 | $100.00K 10-K · filed 2021-02-18 | ||||
| 2018-12-31 | $1.90M 10-K · filed 2020-03-02 | -$1.90M 10-K · filed 2019-03-01 | |||
| 2017-12-31 | $400.00K 10-K · filed 2019-03-01 | ||||
| 2016-12-31 | $100.00K 8-K · filed 2019-01-29 | ||||
| 2015-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$2.00M derived: sum of 2 quarters · filed 2017-03-01 | -$2.00M derived: sum of 3 quarters · filed 2017-03-01 | $300.00K 10-K · filed 2017-03-01 | $2.30M 10-K · filed 2016-02-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $2.30M 10-Q · filed 2015-11-09 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $2.30M 10-Q · filed 2015-08-05 | |||
| 2015-03-31 | $2.30M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |